Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Johnson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Polymers|July 15, 2026
Enhancing Mechanical and Thermal Performance of Injection-Molded PLA via Nucleation and Processing OptimizationPeng Gao, Max Johnson, Duncan Woodward, et al.
Ophthalmic Genetics|January 18, 2017
Reduced penetrance in a large Caucasian pedigree with Stickler syndromeStuart W Tompson, Charles Johnson, Diana Abbott, et al.
Frontiers in Bioengineering and Biotechnology|September 6, 2021
Engineering Functional Vasculature in Decellularized Lungs Depends on Comprehensive Endothelial Cell TropismIfeolu Akinnola, Daniel R Rossi, Carolyn Meyer, et al.
Cell Host & Microbe|June 30, 2021
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseJames Brett Case, Rita E Chen, Longxing Cao, et al.
NPJ Vaccines|October 8, 2024
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogensMarcos C Miranda, Elizabeth Kepl, Mary Jane Navarro, et al.
Frontiers in Immunology|July 16, 2021
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based DesignDaniel Ellis, Natalie Brunette, Katharine H D Crawford, et al.
Cell Reports. Medicine|October 7, 2022
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogensJohn C Kraft, Minh N Pham, Laila Shehata, et al.
Cell Reports|August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceAlexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Polymers|July 15, 2026
Enhancing Mechanical and Thermal Performance of Injection-Molded PLA via Nucleation and Processing OptimizationPeng Gao, Max Johnson, Duncan Woodward, et al.
Ophthalmic Genetics|January 18, 2017
Reduced penetrance in a large Caucasian pedigree with Stickler syndromeStuart W Tompson, Charles Johnson, Diana Abbott, et al.
Frontiers in Bioengineering and Biotechnology|September 6, 2021
Engineering Functional Vasculature in Decellularized Lungs Depends on Comprehensive Endothelial Cell TropismIfeolu Akinnola, Daniel R Rossi, Carolyn Meyer, et al.
Cell Host & Microbe|June 30, 2021
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseJames Brett Case, Rita E Chen, Longxing Cao, et al.
NPJ Vaccines|October 8, 2024
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogensMarcos C Miranda, Elizabeth Kepl, Mary Jane Navarro, et al.
Frontiers in Immunology|July 16, 2021
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based DesignDaniel Ellis, Natalie Brunette, Katharine H D Crawford, et al.
Cell Reports. Medicine|October 7, 2022
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogensJohn C Kraft, Minh N Pham, Laila Shehata, et al.
Cell Reports|August 21, 2022
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceAlexandra C Walls, Laura A VanBlargan, Kai Wu, et al.
Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Pageof 2